SIRT Is Required for EDP-Mediated Protective Responses toward Hypoxia–Reoxygenation Injury in Cardiac Cells by Victor Samokhvalov et al.
fphar-07-00124 May 12, 2016 Time: 16:36 # 1
ORIGINAL RESEARCH
published: 17 May 2016
doi: 10.3389/fphar.2016.00124
Edited by:
Chiranjib Chakraborty,
Galgotias University, India
Reviewed by:
Marco Aurélio Martins,
Oswaldo Cruz Foundation, Brazil
Partha Krishnamurthy,
University of Kansas Medical Center,
USA
*Correspondence:
John M. Seubert
jseubert@ualberta.ca
Specialty section:
This article was submitted to
Experimental Pharmacology and Drug
Discovery,
a section of the journal
Frontiers in Pharmacology
Received: 20 January 2016
Accepted: 28 April 2016
Published: 17 May 2016
Citation:
Samokhvalov V, JamiesonKL,
Fedotov I, Endo T andSeubert JM
(2016) SIRT Is Required
for EDP-Mediated Protective
Responses toward
Hypoxia–Reoxygenation Injury
in Cardiac Cells.
Front. Pharmacol. 7:124.
doi: 10.3389/fphar.2016.00124
SIRT Is Required for EDP-Mediated
Protective Responses toward
Hypoxia–Reoxygenation Injury in
Cardiac Cells
Victor Samokhvalov1, Kristi L. Jamieson1, Ilia Fedotov2, Tomoko Endo1,3 and
John M. Seubert1,4*
1 Faculty of Pharmacy and Pharmaceutical Sciences, Katz Group Centre for Pharmacy and Health Research, University of
Alberta, Edmonton, AB, Canada, 2 Department of Biochemistry, Saratov State Medical University, Saratov, Russia,
3 Department of Pharmacological Sciences, School of Pharmaceutical Sciences, Health Sciences University of Hokkaido,
Hokkaido, Japan, 4 Department of Pharmacology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB,
Canada.
Hypoxia–reoxygenation (H/R) injury is known to cause extensive injury to cardiac
myocardium promoting development of cardiac dysfunction. Despite the vast
number of studies dedicated to studying H/R injury, the molecular mechanisms
behind it are multiple, complex, and remain very poorly understood, which makes
development of novel pharmacological agents challenging. Docosahexaenoic acid
(DHA, 22:6n3) is an n − 3 polyunsaturated fatty acid obtained from dietary
sources, which produces numerous effects including regulation of cell survival
and death mechanisms. The beneficial effects of DHA toward the cardiovascular
system are well documented but the relative role of DHA or one of its more
potent metabolites is unresolved. Emerging evidence indicates that cytochrome
P450 (CYP) epoxygenase metabolites of DHA, epoxydocosapentaenoic acids
(EDPs), have more potent biological activity than DHA in cardiac cells. In this
study we examined whether EDPs protect HL-1 cardiac cells from H/R injury.
Our observations demonstrate that treatment with 19,20-EDP protected HL-1
cardiac cells from H/R damage through a mechanism(s) protecting and enhancing
mitochondrial quality. EDP treatment increased the relative rates of mitobiogenesis and
mitochondrial respiration in control and H/R exposed cardiac cells. The observed EDP
protective response toward H/R injury involved SIRT1-dependent pathways.
Keywords: epoxydocosapentaenoic acids, docosahexaenoic acid, cardiac cells, mitobiogenesis, mitochondrial
function, hypoxia–reoxygenation
INTRODUCTION
The heart is an organ with limited capacity for regeneration and repair, which makes it particularly
vulnerable to various stress factors including ischemia–reperfusion injury (IR; Kimura and
Sadek, 2012). The mechanisms underlying pathogenesis of IR injury are numerous, complex
and not yet fully understood (Lenaz et al., 2010; Gottlieb and Gustafsson, 2011; Kozlov et al.,
2011; Prabhakar and Semenza, 2012). Existing studies consider mitochondrial dysfunction as
a major factor behind the development of cardiac malfunction induced by IR (Solaini et al.,
2010; Walters et al., 2012; Bayeva et al., 2013). Importantly, the disruption of mitochondrial
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oxidative metabolism, ionic homeostasis and biogenesis
results in accumulation of aberrant mitochondria and is
considered the crucial factor contributing to myocardial collapse
(Walters et al., 2012). Further, these aberrant mitochondria
may induce cell death exacerbating the extent of IR injury
(Yamamoto and Sadoshima, 2011; Prabhakar and Semenza,
2012; Walters et al., 2012). Interest in developing strategies
to protect and maintain mitochondrial homeostasis are being
proposed as viable approaches to reduce the deleterious
effects of IR injury (Walters et al., 2012; Bayeva et al.,
2013).
Long-chain n − 3 polyunsaturated fatty acids (PUFAs),
such as Docosahexaenoic acid (DHA), are obtained from
dietary sources and produce a broad spectrum of biological
effects in both cell culture and animal models (Ayalew-
Pervanchon et al., 2007). DHA can be metabolized by CYP
epoxygenases resulting in generation of three-membered ethers
known as epoxides (Wijendran and Hayes, 2004; Zhang
et al., 2014). There are six regioisomeric metabolites termed
epoxydocosapentaenoic acids (EDP; 4,5-, 7,8-, 10,11-, 13,14-,
16,17-, and 19,20-EDP). EDPs have received considerable
attention as potent regulators of various biologic processes such
as inflammation, autophagy, angiogenesis, and insulin signaling
(Xue et al., 2012; Zhang et al., 2013, 2014; Honda et al., 2015). Our
recently published study demonstrated that EDPs are biologically
active metabolites of DHA capable of protecting cardiac cells
through enhancing and preserving mitochondrial quality against
lipopolysaccharide (LPS)-induced cell injury (Samokhvalov et al.,
2015).
Sirtuins (SIRT) belong to a family of proteins that include
NAD+-dependent deacetylases, which activate and regulate
many essential aspects of cell biology such as transcription,
cell death, and inflammation (Nogueiras et al., 2012; Chang
and Guarente, 2014). SIRT1 and SIRT3 are considered central
regulators of cellular homeostasis having positive affects toward
mitochondrial function and biogenesis (Nogueiras et al., 2012).
Moreover, SIRT1 has been shown to govern cellular adaptive
reactions to withstand environmental stressors including hypoxia
(Lin and Guarente, 2003; Chen et al., 2005; Ahn et al., 2008;
Hsu et al., 2010; Lim et al., 2010; Chang and Guarente, 2014; Lu
et al., 2014). Evidence indicates an interaction between SIRT1 and
HIF-1α is important for SIRT1-dependent responses to hypoxia;
however, the precise role of SIRT1 in regulating the adaptive
reactions to hypoxia remains unknown (Lim et al., 2010; Finley
et al., 2011; Yoon et al., 2014). Intriguingly, DHA has been
shown to produce a protective effect toward vascular function
through specific up-regulation of SIRT1 expression (Jung et al.,
2013).
In our recently published study we revealed that EDPs
exerted cytoprotective effects against LPS-induced toxicity
through SIRT1-associated preservation of mitochondrial quality.
Considering, the role SIRT1 has in regulating mitochondrial
quality (Jang et al., 2012; Nogueiras et al., 2012; Chang
and Guarente, 2014), the objective of the current manuscript
was to determine whether SIRT1 mediates EDP-dependent
protective effects against hypoxia–reoxgenation injury in cardiac
cells.
MATERIALS AND METHODS
Cell Culture
HL-1 cardiac cells were a kind gift from Dr. Claycomb (New
Orleans, LA, USA). Cells were cultivated in Claycomb media
supplemented with glutamine and norephinephrine as described.
HL-1 cells were maintained at 37◦C in a humidified atmosphere
of 5% CO2 and 95% air. Cell viability was assessed using the
trypan blue exclusion test. The rate of cell beating was evaluated
by counting the number of beats per minute in five different cell
clusters in five independently blinded experiments.
Hypoxia–Reoxygenation Exposure
Deoxygenated medium was used in all hypoxic experiments. HL-
1 cells were placed in a computer-controlled humidified hypoxic
chamber (0.9% O2, 5%CO2, and 94% N2) for 24 h followed by
reoxygenation under normal (normoxic) conditions for 6 h. The
control cells were exposed to 30 h of normoxia. The hypoxic
chamber and controller were custom-designed and assembled
in the instrumentation workshop at the Faculty of Pharmacy,
University of Alberta, Edmonton, AB, Canada.
Treatment Protocols
HL-1 cells subjected to H/R or normoxia were treated/co-
treated with the following pharmacological agents: 19,20-
EDP (1 µM), DHA (100 µM), N-(methylsulfonyl)-2-(2-
propynyloxy)-benzenehexanamide (MSPPOH, 50 µM), selective
pharmacological inhibitor of CYP epoxygenase activity blocking
formation of endogenous EDPs from DHA and EX-527 (1 µM)
inhibitor of SIRT1 enzymatic activity. Stock solutions of 19,20-
EDP, DHA, MSPPOH, and EX-527 were prepared in 100%
ethanol. Final concentrations of both solvents were less than
0.01% of the treatment solutions. EX-527 was purchased from
Abcam, Cambridge, UK. 19,20-EDP, DHA, and MSPPOH were
obtained from Cayman Chemical, Ann Arbor, MI, USA.
Evaluation of Mitochondrial Function and
Biogenesis
In order to test overall efficiency of mitochondrial oxidative
metabolism we measured the ADP/ATP ratio in cell lysates
using a luciferase-based method (Sigma–Aldrich, Co.,
Oakville, ON, Canada). NAD/NADH ratio was assessed
using a bioluminescent kit (PROMEGA, Madison, WI, USA).
Lactate/Pyruvate ratios were evaluated colorimetrically using
a kit obtained from Sigma–Aldrich (Oakville, ON, Canada).
An MTT assay was employed to examine total oxidative
metabolism as previously described. The intensity of reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
to formazan crystals by mitochondrial dehydrogenases
positively correlates with the overall activity of oxidative
metabolism. Mitochondrial respiration was measured in
saponin-permeabilized HL-1 cardiac cells (Kuznetsov et al.,
2008) using Clark oxygen electrode connected to Oxygraph
Plus recorder (Hansatech Instruments Ltd., Norfolk, England).
Respiration rates were measured at 30◦C before and after
addition of 2 mM ADP in the presence of 5 mM malate and
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10 mM glutamate as respiratory substrates. Respiratory control
ratio (RCR) was calculated as the ratio between basal and ADP-
stimulated respiration rates. Mitobiogenesis was evaluated using
an ELISA kit (ABCAM, Cambridge, UK) based on simultaneous
detection of succinate dehydrogenase (SDH-A), a subunit
of Complex II (nDNA-encoded protein) and cytochrome c
oxidase subunit 1 (COX-1), a subunit of Complex IV (mtDNA-
encoded). The ratio between these proteins reflects the intensity
of mitobiogenesis. Citrate synthase activity was measured
spectrophotometrically using 5,5′-dithiobis(2-nitrobenzoic acid)
as a substrate (Spinazzi et al., 2012).
SIRT1, Caspase 3/7 and 20s Proteasome
Activity Assays
Sirtuins1 enzymatic activity was measured in the whole cell
lysates by using SIRT-Glo [with and without the inhibitor
Trichostatin A (10 mM)] and caspase 3/7 activity by Apo-
ONE assay kits (Promega Corp., Madison, WI, USA) according
to the manufacturer’s instructions. 20s Proteasome activity was
measured in the whole cell lysates using kit from CHEMICON
Inc. (Billerica, MA, USA).
ROS Generation, Total Antioxidant
Activity, and Malondialdehyde (MDA)
Levels
Reactive oxygen species (ROS) production was assessed using a
luminescent-based assay measuring levels of hydrogen peroxide
as a final product of ROS generation (ROS-Glo., Promega
Corp., Madison, WI, USA). We assessed the overall intracellular
antioxidant capacity by measuring the total pool of enzymatic
and non-enzymatic components of the antioxidant system,
which reflects the ability of the cell to withstand oxidative
stress. Briefly, the assay assesses the ability of intracellular small
molecule and protein antioxidants to prevent the conversion
of ABTS 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)
to a radical cation, ABTS+ (Sigma–Aldrich, Co., Oakville, ON,
USA). Accumulation of MDA, a marker of lipid peroxidation,
was determined spectrofluorometrically by assessing products
formed from reactions with thiobarbituric acid (ABCAM,
Cambridge, UK).
NRF1, NRF2, pCREB(Ser133), and HIF-1α
DNA-Binding Assays
NRF1 DNA-binding assay was performed using an ELISA
kit from AssayBioTech (Sunnyvale, CA, USA), pCREB(Ser133)
DNA-binding activity was measured using an ELISA kit from
Cayman Chemical (Ann Arbor, MI, USA). NRF2, and HIF-
1α DNA-binding assays were performed using ELISA kits from
Active Motif (Carlsbad, CA, USA).
Statistical Analysis
Data are presented as mean± SEM. Statistical analysis was based
on one-way ANOVA with a Bonferonni post hoc test; p < 0.05
was considered statistically significant.
RESULTS
EDPs Trigger Adaptive Responses in
HL-1 Cells Protecting against H/R Injury
Exposure of HL-1 cardiac cells to H/R promoted a dramatic
decrease in cell viability revealed by a trypan blue exclusion assay
(Figure 1A). Cells subjected to H/R injury had a significantly
reduced response in the MTT test indicative of severe
impairments in mitochondrial oxidative activity (Figure 1B).
Mature cardiomyocytes rely heavily on mitochondria to provide a
continuous supply of ATP to meet energy demands for contractile
activity (Ardehali et al., 2012; Bayeva et al., 2013). H/R-impaired
mitochondrial metabolism resulted in severely compromised
contractile activity of HL-1 cardiac cells as shown in Figure 1C.
Increased 20S proteasome activity reflects activation of cellular
degenerative processes that remove damaged proteins in
response to significant stress (Samokhvalov et al., 2013). In this
study we demonstrated that H/R injury triggered significant
increases in 20S proteasome activity indicative of extensive
accumulation of cellular damage (Figure 1D). Additionally, our
H/R injury protocol triggered caspase 3/7 activities, instigating
an apoptotic response in the exposed HL-1 cells (Figure 1E).
This is consistent with studies demonstrating an essential role
for apoptosis in hypoxia-associated cell death (Hsu et al.,
2010; Kimura and Sadek, 2012; Walters et al., 2012). Together,
our findings support a concept where H/R exposure induces
extensive mitochondrial injury causing metabolic exhaustion
and eventually death of cardiac cells. Remarkably, addition of
19,20-EDP robustly protected cardiac cells against H/R-induced
dysfunction and death (Figures 1A–E) producing a strong
cytoprotective effect.
Docosahexaenoic acid has been characterized as a biologically
active molecule capable of evoking and orchestrating numerous
adaptive responses protecting the myocardium (Leaf, 1990;
Wijendran and Hayes, 2004; Ayalew-Pervanchon et al., 2007).
Interestingly, we previously demonstrated the protective
response of DHA against LPS-induced cardiotoxicity is largely
mediated by its endogenously produced metabolites, EDPs
(Samokhvalov et al., 2015). In this study we investigated whether
formation of endogenous EDPs has an essential role in DHA-
associated protection. HL-1 cells were subjected to H/R and
DHA with or without MSPPOH, a CYP epoxygenase inhibitor
to block formation of endogenous EDPs. Although treatment
with DHA resulted in significant protection of HL-1 cardiac
cells against H/R-induced injury, these effects were abolished by
co-treatment with MSPPOH (Figures 1A–E). Thus suggesting
DHA-mediated protective effects are attributed to increased
generation of endogenously produced EDPs.
EDPs Limit Cellular Oxidative Stress
Triggered by H/R Exposure
In response to H/R injury cells must activate adaptive responses
to cope with deleterious consequences to survive (Kimura and
Sadek, 2012; Prabhakar and Semenza, 2012; Guimaraes-Camboa
et al., 2015). Activation of oxidative stress is an important
factor contributing to hypoxic cell death, where dysfunctional
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FIGURE 1 | Epoxydocosapentaenoic acids (EDPs) preserve HL-1 cardiac cell viability from hypoxia–reoxygenation (H/R) injury. HL-1 cardiac cells were
subjected to either 30 h normoxia or 24 h hypoxia and 6 h reoxygenation in the presence of 19,20-EDP (1 µM), docosahexaenoic acid (DHA; 100 µM) and/or
(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide (MSPPOH; 50 µM). Treatment of HL-1 cells exposed with DHA or EDPs during H/R injury resulted in (A)
preserved cell viability, (B) enhanced mitochondrial activity, and (C) better contractility. Furthermore, both (D) proteasomal, and (E) caspase 3/7 activities were
attenuated. Values are represented as mean ± SEM; N = 3 independent experiments; ∗p < 0.05 treatment vs. normoxic control, #p < 0.05 treatment group vs. H/R
control or DHA/N-MSPPOH.
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mitochondria are a major source of ROS generation (Lenaz et al.,
2010; Solaini et al., 2010; Kimura and Sadek, 2012; Walters
et al., 2012). Our observations demonstrate that HL-1 cells have
significantly reduced abilities to withstand oxidative stress caused
by our H/R injury model. We demonstrate that exposing HL-
1 cardiac cells to H/R injury results in a significant activation
of ROS generation (Figure 2A), which is associated with a
compromised antioxidant defense capacity (Figure 2B). Taken
together this would result in increased oxidative injury, which is
reflected by the elevated levels of MDA (Figure 2C). Importantly,
while treatment of HL-1 cells with 19,20-EDP did not reduce ROS
generation, it preserved the total antioxidant capacity thereby
limiting detrimental effects of oxidative stress as illustrated
by the reduced MDA levels (Figures 2B,C). DHA-mediated
protection was blocked by inhibiting CYP epoxygenase activity
with MSPPOH, indicating the epoxy metabolites generated
from DHA are essential components of the protective effect
(Figures 2B,C).
EDPs Preserve Mitochondrial Function
Compromised by H/R Injury
Although cardiac mitochondria are involved in regulation of
numerous signaling pathways they are best known as the
powerhouse of cardiomyocytes where respiration is tightly
coupled with generation of ATP (Porter et al., 2011). The
ratio between mitochondrial oxygen consumption in basal and
ADP-stimulated states is commonly referred as respiratory ratio
control (RCR) and applied to express efficiency of mitochondrial
function (Kuznetsov et al., 2008). Indeed, high RCR allows
cardiomyocytes to maintain a low ADP/ATP ratio, which is
required for an optimally functioning heart (Porter et al.,
2011; Ardehali et al., 2012). It has been clearly shown that
H/R insult selectively targets and produces severe injury of
mitochondria through distinct mechanisms. Resultant aberrant
mitochondria can communicate their fitness to the rest of the
cardiomyocyte and trigger cell death (Solaini et al., 2010; Walters
et al., 2012). In order to determine mitochondrial function in
cardiac cells we assessed ADP/ATP ratio as well as RCR. A
dramatic increase in ADP/ATP ratio illustrates suppression of
mitochondrial oxidative phosphorylation in HL-1 cells developed
in response to H/R conditions (Figure 3A). This finding was
further supported with another observation where cells exposed
to H/R responded with a drastic decline in RCR (Figure 3B).
Citrate synthase activity has been described and well documented
as a reliable marker of mitochondrial content (Larsen et al., 2012).
According to our experiments, exposure to H/R significantly
lowered activity of citrate synthase suggesting a decrease in
mitochondrial content (Figure 3C). Treatment with 19,20-EDP-
enhanced citrate synthase activity suggesting the preservation
of an optimally functioning mitochondrial pool preventing the
detrimental effects of H/R injury (Figures 3A–C). Treatment
with DHA-produced protective effects sensitive to inhibition by
MSPPOH illustrating a pivotal role of endogenously generated
EDPs in mediating DHA-induced protection.
EDPs Preserve Mitobiogenesis in
Cardiac Cells Disrupted by H/R Injury
Mitochondrial biogenesis is a mechanism responsible for
generation of new mitochondria forming a population of
more bioenergetically robust organelles and representing a
biologically important strategy of cell survival (Gottlieb and
Gustafsson, 2011). The biological relevance of mitobiogenesis
comes from mitochondria’s central role in regulating energy
production, oxygen homeostasis, and programmed cell death
(Porter et al., 2011; Walters et al., 2012). Mitochondrial biogenesis
is controlled through a complex process involving transcriptional
factors such as NRF1/2, CREB, and PGC-1α (Scarpulla, 2008).
Exposure of HL-1 cardiac cells to H/R resulted in a strong
suppression of mitobiogenesis based on the altered ratio of COX-
1 (mtDNA-encoded) and SDH-A (nDNA-encoded) expression
FIGURE 2 | Epoxydocosapentaenoic acids limit H/R-induced cellular oxidative stress responses. HL-1 cardiac cells were subjected to either 30 h
normoxia or 24 h hypoxia and 6 h reoxygenation in the presence of 19,20-EDP (1 µM), DHA (100 µM), and/or MSPPOH (50 µM). Treatment of HL-1 cells exposed
with DHA or EDPs during H/R injury did not affect generation of ROS (A), while preserved total cellular antioxidant capacity (B) and decreased accumulation of MDA
(C). Values are represented as mean ± SEM; N = 3 independent experiments; ∗p < 0.05 treatment vs. normoxic control, #p < 0.05 treatment group vs. H/R control
or DHA/MSPPOH.
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FIGURE 3 | EDPs preserve mitochondrial function following H/R injury. HL-1 cardiac cells were subjected to either 30 h normoxia or 24 h hypoxia and 6 h
reoxygenation in the presence of 19,20-EDP (1 µM), DHA (100 µM), and/or MSPPOH (50 µM). Treatment of HL-1 cells with DHA or EDPs during H/R injury
sustained (A) the intracellular ratio between ADP and ATP, (B) enhanced and protected mitochondrial respiration and finally, (C) limited the drop in citrate synthase
(CS) activity (a marker of mitochondrial content) caused by H/R injury. The ratio between basal and ADP-stimulated respiration is presented as respiratory control
ratio (RCR). Activity of CS was used as a marker of mitochondrial content. Values are represented as mean ± SEM; N = 3 independent experiments; ∗p < 0.05
treatment vs. normoxic control, #p < 0.05 treatment group vs. H/R control or DHA/MSPPOH.
in the same cell (Figure 4A). In addition, we observed
exposure to H/R conditions results in severe inhibition of NRF1,
NRF2, and pCREB(Ser133) DNA-binding activities in HL-1
cardiac cells. Together mitochondrial biogenesis in HL-1 cardiac
cells was significantly disrupted in response to H/R injury.
Interestingly, the addition of 19,20-EDP resulted in
a significant activation of mitobiogenesis assessed in
normoxic cells (Figures 4A–D), which is consistent
with our previously published study demonstrating a
pronounced ability of EDPs to stimulate mitobiogenesis
in cardiac cells (Samokhvalov et al., 2015). Treatment
of cardiac cells with 19,20-EDP prevented the impaired
mitobiogenic response caused H/R injury. Figures 4A–D
clearly demonstrates that overall mitobiogenesis is significantly
higher in H/R injured cells treated with 19,20-EDP. Similarly,
protective effects of DHA against H/R associated decline in
mitobiogenesis was abolished by MSPPOH, which firmly
indicates a crucial role of endogenously generated EDPs
(Figures 4A–D).
EDPs Restore SIRT1 Activity,
NAD+/NADH and Lactate/Pyruvate
Ratios Altered by HR Injury
In response to various environmental stressors, SIRT1 is
dynamically regulated at each step from transcription to protein
activation (Nogueiras et al., 2012). Upregulation of SIRT1 results
in activation of biologically relevant processes evoking diverse
pathways of adaptation (Lee et al., 2008; Hsu et al., 2010;
Nadtochiy et al., 2011b; Nogueiras et al., 2012; Lu et al.,
2014; Yoon et al., 2014). Interestingly, in a previous study
we demonstrated an essential role of SIRT1 in mediating
EDP-induced protection of cardiac cells against LPS-induced
cytotoxicity (Samokhvalov et al., 2015). In this study we examined
the role of SIRT1 in EDP-mediated protection against H/R
injury. First, we observed that intracellular SIRT1 activity was
significantly inhibited following H/R injury (Figure 5A). Second,
paralleling our observations of decreased SIRT1 activity, H/R
exposure triggered a profound decrease in the NAD+/NADH
ratio (Figure 5B). An increase in NADH levels down-regulates
SIRT1 during hypoxia (Lin and Guarente, 2003; Lim et al.,
2010). Moreover, H/R injury triggered a significant shift in
the lactate/pyruvate ratio indicating increased acidification
(Figure 5C). Treatment with 19,20-EDP resulted preserving
SIRT1 activity and both NAD+/NADH and lactate/pyruvate
ratios (Figures 5A–C). Treatment with DHA produced similar
but sensitive to MSPPOH inhibition results, which further
highlights an important contribution of endogenous EDPs.
Suppression of SIRT1 Enzymatic Activity
through Pharmacological Inhibiton
Abolishes the Protective Effects of
19,20-EDP against H/R Injury
To determine if 19,20-EDP-mediated protection against H/R
insult requires activation of SIRT1, we treated HL-1 cells
with specific inhibitor of SIRT1 enzymatic activity, EX-
527. Recently published data indicate it is SIRT1 enzymatic
activity, not the level of expression, which determines overall
activity of SIRT-dependent pathways (Gurd et al., 2011).
We found that pharmacological inhibition of SIRT1 activity
resulted in a complete loss of 19,20-EDP-associated protection,
as observed by changes to cell viability and mitochondrial
activity (Figures 6A,B). Moreover, suppression of SIRT1 activity
prevented 19,20-EDP- mediated mitobiogenesis (Figure 6C).
Interestingly, treatment with 19,20-EDP strongly reduced HIF-
1α DNA binding activity, whereas co-treatment with EX-527
completely depressed this effect (Figure 6D). Thus, these data
strongly suggest that the protective effects of 19,20-EDP against
H/R model in HL-1 cardiac cells injury requires SIRT1 activity.
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FIGURE 4 | EDPs induce mitobiogenesis in HL-1 cardiac cells. HL-1 cardiac cells were subjected to either 30 h normoxia or 24 h hypoxia and 6h reoxygenation
in the presence of 19,20-EDP (1 µM), DHA (100 µM), and/or MSPPOH (50 µM). (A) Relative rates of mitobiogenesis were assessed using an ELISA assay detecting
simultaneous expression of SDH-A (nDNA-encoded protein) and COX-I (mtDNA-encoded protein) in each well of plated HL-1 cells. The ratio between COX-I and
SDH-A expressions represents the relative rate of mitobiogenesis. EDPs increased the relative rates of mitobiogenesis and while preserving the decline following H/R
injury. Increased levels of DHA or EDPs in HL-1 cells increased (B) NRF1, (C) NRF2, and (D) pCREB(Ser133) DNA-binding activity. Values are represented as
mean ± SEM; N = 3 independent experiments; ∗p < 0.05 treatment vs. normoxic control, #p < 0.05 treatment group vs. H/R control or DHA/MSPPOH.
DISCUSSION
Cytochrome P450 epoxygenases metabolize PUFA into
biologically active epoxy derivates (Wijendran and Hayes,
2004; Zhang et al., 2014). Although numerous studies
demonstrate EDP-dependent regulation of inflammation,
angiogenesis and cell survival/death pathways, the molecular
mechanisms underlying these effects remain unknown
(Panigrahy et al., 2013; Zhang et al., 2013, 2014; Samokhvalov
et al., 2014; Lopez-Vicario et al., 2015). Our recent study
shed some light on possible mechanisms through which EDPs
promote protection (Samokhvalov et al., 2015). While we
demonstrated the importance of SIRT1 activity in mediating
EDP-mediated protection against LPS-induced cytotoxicity,
it was unknown whether this was specifically attributed to
an LPS model of cytotoxicity or represented a biologically
versatile adaptive response. In this study we demonstrate
EDPs protect HL-1 cardiac cells from H/R-injury of cardiac
cells by preserving and maintaining a functioning pool
of mitochondria. The cornerstone of this study suggests
a significant role for SIRT1 in mediating EDP-associated
protection.
Several lines of evidence suggest maintaining mitochondrial
homeostasis and integrity is directly linked to cellular protection
under conditions of H/R, which has been documented in a
diverse array of models (Solaini et al., 2010; Kozlov et al., 2011;
Walters et al., 2012). Hypoxic cells will activate HIF-1α to in
response to the metabolic crisis, which initiates reprogramming
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FIGURE 5 | EDPs induce SIRT1 activity in HL-1 cardiac cells. HL-1 cardiac cells were subjected to either 30 h normoxia or 24 h hypoxia and 6h reoxygenation
in the presence of 19,20-EDP (1 µM), DHA (100 µM), and/or MSPPOH (50 µM). EDPs increased both (A) intracellular SIRT1 enzymatic activity and (B) NAD+/NADH
ratios in HL-1 cells. (C) EDPs and DHA prevented the increase in lactate/pyruvate ratio following H/R injury. Values are represented as mean ± SEM; N = 3
independent experiments; ∗p < 0.05 treatment vs. normoxic control, #p < 0.05 treatment group vs. H/R control or DHA/MSPPOH.
events including suppressing oxidative phosphorylation and
mitobiogenesis while activating glycolysis in an attempt to
compensate for ATP deficiency (Schmid et al., 2004; Lenaz
et al., 2010; Kimura and Sadek, 2012; Walters et al., 2012; Yoon
et al., 2014; Guimaraes-Camboa et al., 2015). Reoxygenation
can trigger a number of adverse reactions where a robust
increase ROS generation and collapse of antioxidant defense
result in detrimental effects (Kozlov et al., 2011; Kimura
and Sadek, 2012; Walters et al., 2012; Bayeva et al., 2013).
The accumulating effects of mitochondrial oxidative injury in
cardiomyocytes exposed to hypoxic injury ultimately results in
apoptotic cell death (Hsu et al., 2010; Yamamoto and Sadoshima,
2011).
Sirtuins consist of a class of proteins that possess NAD+-
dependent deacetylase activity, in which the specific isozyme,
SIRT1, has a role in mediating life span extension and triggering
adaptive responses toward a broad spectrum of stressors (Chen
et al., 2005; Chang and Guarente, 2014; Lu et al., 2014).
Thus suggesting activation of SIRT1 may confer resistance to
H/R injury. Important to SIRT1 function is the ratio between
NAD+ and NADH, which is modulated by nutrients, energy
consumption and hypoxia. Hypoxia is known to dramatically
reduce the NAD+/NADH ratio due to decreased consumption
of NADH in mitochondria while an increased supply from
glycolysis down-regulating SIRT1 (Lin and Guarente, 2003;
Hsu et al., 2010; Lim et al., 2010; Nadtochiy et al., 2011a,b;
Lu et al., 2014; Yoon et al., 2014). Our current data are
consistent with these experimental observations. Interestingly,
cardiomyocyte-specific overexpression of SIRT1 protects against
IR injury, whereas cardiac-specific down-regulation of SIRT1
increases IR injury through transcriptional and post-translational
mechanisms (Hsu et al., 2010). Published studies indicate SIRT1
protects the heart from IR through attenuation of oxidative stress
and protection of mitochondrial function (Alcendor et al., 2007).
Accumulating evidence considers SIRT1 as an essential
regulator of mitochondrial function and biogenesis (Scarpulla,
2008; Nogueiras et al., 2012; Chang and Guarente, 2014).
Enzymatic reactions catalyzed by SIRT1 require the cofactor
NAD+ to deacetylate a wide range of proteins including
PGC1α (Lin and Guarente, 2003; Scarpulla, 2008; Nogueiras
et al., 2012). SIRT1-dependent activation mitobiogenesis as an
adaptive reaction to various pathophysiological factors, such
as starvation, disrupted glucose homeostasis, oxidative stress,
aging and cardiovascular disease (Chen et al., 2005; Hsu et al.,
2010; Iwabu et al., 2010; Nadtochiy et al., 2011a,b; Nogueiras
et al., 2012; Lu et al., 2014; Yoon et al., 2014). Moreover, SIRT1
can enhance mitochondrial function by activating oxidative
phosphorylation and suppressing glycolysis (Chen et al., 2005;
Zhang et al., 2007; Scarpulla, 2008; Nogueiras et al., 2012;
Chang and Guarente, 2014). Furthermore, a direct piece of
evidence indicates that SIRT1 triggers the deacetylation of
essential autophagic proteins thereby promoting the selective
removal of damaged mitochondria through mitophagy, which
ultimately results in positively altered mitochondrial quality.
Together, these studies support a concept where activation of
SIRT1 is required to enhance and sustain optimal mitochondrial
quality through promoting biogenesis and simultaneous removal
of damaged mitochondria (Lee et al., 2008; Jang et al., 2012).
The dual positive regulatory role SIRT1 toward mitochondrial
quality results in selecting and maintaining a highly functional
pool of mitochondria. Our observations described in this study
demonstrate that protective effects exerted by EDPs against
H/R injury resulted in improved mitochondrial quality. This
was highlighted by enhanced respiration rates, ADP/ATP ratios
and increased citrate synthase activity suggesting that the
preservation of mitochondrial content results in a pool of healthy
mitochondria, which protects cardiac cells undergoing H/R
injury.
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FIGURE 6 | Inhibition of SIRT1 activity abolished 19,20-EDP protective effects against H/R induced cytotoxicity. HL-1 cardiac cells were subjected to
either 30 h normoxia or 24 h hypoxia and 6 h reoxygenation in the presence of 19,20-EDP (1 µM) and EX-527 (1 µM) for 24 h. Inhibition of SIRT1 activity blocked
DHA and EDP protective effects toward (A) cell viability and (B) mitochondrial activity as assessed by MTT assay. (C) The relative rates of increased mitobiogenesis
triggered by EDPs were attenuated by inhibition of SIRT1 activity. (D) EDPs limited HIF-1α DNA-binding activity caused by H/R injury, which were blocked by
inhibiting SIRT1 activity. Values are represented as mean ± SEM; N = 3 independent experiments; ∗p < 0.05 treatment vs. normoxic control, #p < 0.05 treatment
group vs. H/R control or DHA/MSPPOH.
Importantly, our study indicates that 19,20-EDP affects
transcriptional activity of HIF-1α in HL-1 cells subjected to
H/R injury. Exposure of cells to H/R conditions results in
a situation when cells readily respond by inducing adaptive
pathways governed by HIF-1α and thereby HIF-1α is suggested
to play a positive role in adaptation to hypoxia (Prabhakar and
Semenza, 2012; Guimaraes-Camboa et al., 2015). Treatment with
19,20-EDP promoted viability and functional activity of
H/R-injured cardiac cells while suppressing HIF-1α
transcriptional activity. Although the discrepancies between
these studies and ours could be due to the differences in
experimental objectives and design, we propose possible
explanations supporting our observation. First, it has been
shown that SIRT1 can modulate cellular responses to hypoxia
by direct deacetylating and inactivating HIF-1α (Lim et al.,
2010). Although SIRT1 is normally down-regulated during
hypoxia, treatment with EDPs resulted in strong activation of
SIRT1 activity. This EDPs-induced activation of SIRT1 could
result in inactivation of HIF-1α. Second, under prolonged
exposure to hypoxia, pro-survival effects of HIF-1α can be
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FIGURE 7 | Schematic – activation of SIRT1 activity by EDPS is required to exert protective effects. H/R injury overactivates HIF-1α resulting in
mitochondrial injury. Subsequently, the compromised mitochondria rapidly promote cell dysfunction and cell death. EDPs act as positive and possibly, selective
modulators of SIRT1 activity, through yet to be identified molecular mechanisms, initiating important adaptive responses. SIRT1 can (i) act as a potent suppressor of
HIF-1α, (ii) rapidly and potently activate mitobiogenesis, and (iii) selectively eliminate damaged mitochondria via mitophagy. EDP-mediated activation of SIRT1
signaling promotes physiological events that enhance mitochondrial quality control. Thus, preserving a healthy and optimally functioning pool of mitochondria, which
protect the cell from LPS-induced toxicity.
blocked through complex interplay between at least two distinct
pathways: p53-triggered degradation of HIF-1α and competition
for the limiting transcriptional co-activator p300 (Schmid
et al., 2004; Zhang et al., 2007). Although we did not examine
the role of p53-dependent pathways in down-regulation of
HIF-1α transcriptional activity, we still cannot entirely rule
out this possibility. Finally, prolonged activation of HIF-1α
in myocardium results in the phenomenon of maladaptation
characterized by rapid induction of deleterious reactions leading
injury and consequent death of cardiac cells (Prabhakar and
Semenza, 2012).
CONCLUSION
We suggest that prolonged activation of HIF-1α in cardiac
cells triggers overactivation of glycolysis leading to acidification,
as observed by an increased ratio between lactate and
pyruvate, where acidification acts as a toxicant triggering
death of cardiomyocytes. Moreover, activating HIF-1α down-
regulates key mitochondrial machinery, which is detrimental to
cardiomyocytes over the long-term run as metabolic activity
and cellular function are strongly dependent on optimally
functioning mitochondria. Previously, we have demonstrated
that EDP- and DHA-dependent effects may differ between
cell types where a beneficial mitochondrial-mediated effect is
observed in primary neonatal cardiomyocytes and HL-1 cardiac
cells compared to increased cell death in rat H9c2 cells (Qadhi
et al., 2013; Samokhvalov et al., 2015). Our current results provide
further evidence supporting the notion that EDPs provide
protective effects via the mitochondria. In summary, our study
demonstrates that EDPs exert cytoprotective effects against H/R
injury by preserving a healthy and optimally functioning pool
of mitochondria in HL-1 cardiac cells. EDPs activate a SIRT1-
dependent mechanism promoting pro-survival mechanisms to
allow cells the ability to effectively H/R injury (Figure 7).
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